Expertise in
4
conditions

Ann S. Mertens

Leuven, VLG, BE 
Expertise in
4
conditions
Leuven, VLG, BE 

Overview

Ann Mertens practices practicing medicine in Leuven, Belgium.

Ms. Mertens is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Obesity, Epilepsy, Sleeve Gastrectomy, and Gastric Bypass.

She is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Leuven, VLG, Belgium
Other Locations
Gent, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
Hepcidin Behavior in Patients With Obesity and Bariatric Surgery
Hepcidin Behavior in Patients With Obesity and Bariatric Surgery
Enrollment Status: Terminated
Publish Date: July 03, 2024
Intervention Type: Other
Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Enrollment Status: Completed
Publish Date: February 14, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
View 4 Less Clinical Trials

139 Total Publications

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.
Journal: Atherosclerosis
Published: March 18, 2026

Frequently Asked Questions about Ann S. Mertens

Is Ann S. Mertens a top-rated expert for Familial Partial Lipodystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Ann S. Mertens is classified as an Advanced expert for Familial Partial Lipodystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ann S. Mertens participate in research or clinical trials?

Yes. Ann S. Mertens has published 139 articles and abstracts on conditions like Familial Partial Lipodystrophy. You can view a list of Ann S. Mertens's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mertens's expertise for a condition
ConditionClose
      View All 29 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile